Maggie® 5.0
Maggie® 5.0 is an innovative, large-volume, cartridge-based autoinjector technology built with our market-proven Needle Isolation Technology (NIT®).
Meet Maggie® 5.0 mL
For specific and large-volume formulation
Maggie® 5.0 mL accommodates a wider variety of formulation characteristics and volumes that are not possible with pre-filled syringe-based autoinjectors.
Specifications
- Viscosity
- high
- Volume
- 5.0 ml
- Device type
- Disposable autoinjector
- Primary container
- Cartridge with pre-installed needle (NIT®)
- Route of administration
- Subcutaneous
- Connectivity
- No
- Dosage type
- Fixed dose | Optional automated priming and titration
- Activation method
- Needle cover
- Injection feedback
- Continuous audible clicks, viewing window
- Customization
- Yes
Needle Isolation Technology (NIT)
NIT® is a market-proven, pre-attached needle technology for cartridge-based injections that eliminates the need for patients to manually attach the needle. NIT provides complete control of cannula gauge and length to support target injection time and injection depth.
The first NIT-enabled autoinjector received regulatory approval in 2017 for a metabolic treatment. In 2024, a second device was approved for treatment of two dermatological conditions.
Advancing large-volume subcutaneous autoinjection
Cartridge-based solutions
Maggie® 5.0 is designed for large-volume subcutaneous drug delivery using a 5.0 mL cartridge with pre-installed needle.
Supply chain partnerships
Maggie® 5.0 is supported by an integrated supply chain, from primary container components and drug filling to final device assembly.